Total Payments
$6,548
2023 Payments
$276.96
Companies
31
Transactions
439
Medicare Patients
3,317
Medicare Billing
$899,508
Payment Breakdown by Category
Food & Beverage$6,068 (92.7%)
Travel$309.08 (4.7%)
Education$170.66 (2.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,068 | 435 | 92.7% |
| Travel and Lodging | $309.08 | 1 | 4.7% |
| Education | $170.66 | 3 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,452 | 103 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,057 | 88 | $0 (2023) |
| Janssen Biotech, Inc. | $723.38 | 51 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $403.10 | 27 | $0 (2023) |
| Covidien LP | $322.96 | 2 | $0 (2017) |
| Ferring Pharmaceuticals Inc. | $262.32 | 19 | $0 (2023) |
| Ironwood Pharmaceuticals, Inc | $207.55 | 14 | $0 (2021) |
| Gilead Sciences, Inc. | $196.63 | 15 | $0 (2021) |
| Daiichi Sankyo Inc. | $185.87 | 13 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $182.15 | 10 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $276.96 | 19 | ABBVIE INC. ($134.99) |
| 2022 | $553.32 | 39 | ABBVIE INC. ($286.11) |
| 2021 | $1,100 | 74 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($249.42) |
| 2020 | $777.79 | 61 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($380.51) |
| 2019 | $863.77 | 64 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($227.16) |
| 2018 | $970.80 | 79 | AbbVie, Inc. ($180.46) |
| 2017 | $2,005 | 103 | AbbVie, Inc. ($556.28) |
All Payment Transactions
439 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/19/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/19/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Gastroenterology | ||||||
| 03/30/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: VIROLOGY | ||||||
| 03/23/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: VIROLOGY | ||||||
| 03/21/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/09/2023 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/08/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/08/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.89 | General |
| Category: Neuroscience | ||||||
| 03/05/2023 | ABBVIE INC. | RINVOQ (Biological), HUMIRA | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: IMMUNOLOGY | ||||||
| 03/02/2023 | ABBVIE INC. | RINVOQ (Biological), HUMIRA | Food and Beverage | In-kind items and services | $2.29 | General |
| Category: IMMUNOLOGY | ||||||
| 03/01/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $16.42 | General |
| Category: THERAPY FOR CSID | ||||||
| 03/01/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: IMMUNOLOGY | ||||||
| 02/22/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/08/2023 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/08/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Gastroenterology | ||||||
| 02/08/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: IMMUNOLOGY | ||||||
| 01/26/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: VIROLOGY | ||||||
| 01/19/2023 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/11/2023 | Ferring Pharmaceuticals Inc. | CIMZIA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/30/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Gastroenterology | ||||||
| 11/30/2022 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/15/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.90 | General |
| Category: Neuroscience | ||||||
| 11/02/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Immunology | ||||||
| 10/05/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 322 | 339 | $170,309 | $31,754 |
| 2022 | 16 | 987 | 14,650 | $1.2M | $338,438 |
| 2021 | 19 | 988 | 12,548 | $1.3M | $329,031 |
| 2020 | 21 | 1,020 | 6,919 | $621,933 | $200,285 |
Total Patients
3,317
Total Services
34,456
Medicare Billing
$899,508
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 98 | 99 | $81,589 | $7,686 | 9.4% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 101 | 101 | $14,165 | $6,910 | 48.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 31 | 32 | $37,213 | $6,903 | 18.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 46 | 77 | $12,312 | $4,810 | 39.1% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 18 | 36 | $9,876 | $4,643 | 47.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 36 | 36 | $8,360 | $4,461 | 53.4% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 27 | 27 | $27,410 | $3,338 | 12.2% |
| 45384 | Removal of polyps or growths in large bowel using an endoscope | Facility | 2020 | 17 | 17 | $19,580 | $3,129 | 16.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2020 | 15 | 15 | $13,190 | $3,080 | 23.4% |
| 45378 | Diagnostic examination of large bowel using an endoscope | Facility | 2020 | 19 | 19 | $15,870 | $2,956 | 18.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 49 | 83 | $6,333 | $2,760 | 43.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 22 | 22 | $6,207 | $2,628 | 42.3% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 17 | 17 | $2,550 | $1,473 | 57.8% |
| 43236 | Injections of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 11 | 11 | $9,300 | $1,238 | 13.3% |
| 43450 | Dilation of esophagus | Facility | 2020 | 13 | 13 | $4,455 | $458.72 | 10.3% |
| 82272 | Stool analysis for blood | Office | 2020 | 40 | 40 | $400.00 | $168.16 | 42.0% |
About Dr. Jay Malamut, M.D
Dr. Jay Malamut, M.D is a Specialist healthcare provider based in Haddon Heights, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1881682367.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jay Malamut, M.D has received a total of $6,548 in payments from pharmaceutical and medical device companies, with $276.96 received in 2023. These payments were reported across 439 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($6,068).
As a Medicare-enrolled provider, Malamut has provided services to 3,317 Medicare beneficiaries, totaling 34,456 services with total Medicare billing of $899,508. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Gastroenterology
- Location Haddon Heights, NJ
- Active Since 10/10/2005
- Last Updated 05/31/2023
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1881682367
Products in Payments
- XIFAXAN (Drug) $831.67
- STELARA (Biological) $683.14
- Humira (Biological) $405.35
- PillCam (Device) $322.96
- LINZESS (Drug) $252.60
- Mavyret (Drug) $197.83
- Cimzia (Drug) $177.27
- Entyvio (Biological) $171.80
- INJECTAFER (Drug) $170.31
- Creon (Drug) $169.02
- REMICADE (Biological) $167.22
- ENTYVIO (Biological) $142.83
- CLENPIQ (Drug) $138.11
- VIBERZI (Drug) $118.94
- XIFIXAN (Drug) $118.72
- HUMIRA (Biological) $117.63
- Sucraid (Drug) $117.50
- APRISO (Drug) $115.02
- MAVYRET (Drug) $112.31
- RINVOQ (Biological) $111.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Haddon Heights
John Kolnik, D.o, D.O
Specialist — Payments: $158,544
Specialist $158,544
James Izanec, Md, MD
Specialist — Payments: $14,506
Specialist $14,506
M Arif Hashmi, M.d, M.D
Specialist — Payments: $6,424
Specialist $6,424
Dr. Denise Mastromonaco, D.o, D.O
Specialist — Payments: $2,690
Specialist $2,690
Boris Libster, D.o, D.O
Specialist — Payments: $1,410
Specialist $1,410
Howard Siegel, M.d, M.D
Specialist — Payments: $1,353
Specialist $1,353